Arginase: Potential Drug Target Or Biomarker (P14457)

Target Name: Arginase

NCBI ID: P14457

Arginase

Other Name(s): None

Arginase: Potential Drug Target Or Biomarker

Arginase (nonspecified subtype) is a protein that plays a critical role in cellular signaling and metabolism. It is an enzyme that catalyzes the conversion of arginine (A) to nitric oxide (NO), which is a signaling molecule that regulates various physiological processes in the body. Arginase is a key enzyme in the production of nitric oxide, which is important for maintaining blood flow, oxygenation, and cell signaling.

Mutations in the arginase gene have been linked to various diseases, including cardiovascular disease, diabetes, and cancer. The arginase gene has also been implicated in several diseases, including age-related macular degeneration (AMD), neurodegenerative diseases, and cancer. Therefore, the study of arginase and its role in disease has become a topic of intense interest in the scientific community.

Arginase has been identified as a potential drug target or biomarker due to its involvement in various diseases. Its role in the production of nitric oxide makes it an attractive target for those treating cardiovascular disease. Nitric oxide is a powerful signaling molecule that plays a critical role in the regulation of blood flow, blood pressure, and oxygenation. Therefore, increasing nitric oxide production can improve blood flow and oxygenation, which can lead to a wide range of health benefits.

Arginase has also been shown to be involved in the development and progression of certain diseases, including AMD and cancer. AMD is a progressive disease that leads to the death of photoreceptor cells in the retina, leading to a loss of vision. to be involved in the production of reactive oxygen species (ROS) that can damage photoreceptor cells and contribute to AMD progression. Similarly, arginase has also been shown to be involved in the development and progression of cancer, by participating in the production of ROS.

In addition to its role in disease, arginase has also been shown to be a potential biomarker for several diseases. The levels of arginase in tissues, fluids, or blood have been shown to be elevated in individuals with certain diseases, such as cancer, cardiovascular disease, and neurodegenerative diseases. Therefore, measuring the levels of arginase in these diseases can be a useful diagnostic tool and may have implications for personalized medicine.

In conclusion, arginase is a protein that plays a critical role in cellular signaling and metabolism. Its role in the production of nitric oxide makes it an attractive target for those treating cardiovascular disease. Its involvement in the development and progression of certain diseases, including AMD and cancer, also makes it a potential biomarker for these diseases. Further research is needed to fully understand the role of arginase in disease and its potential as a drug target or biomarker.

Protein Name: Arginase (nonspecified Subtype)

The "Arginase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Arginase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets